TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmex AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,206
|
2,154
|
1,720 |
| Financial expenses |
68
|
79
|
10 |
| Earnings before taxes |
322
|
317
|
234 |
| Total assets |
972
|
876
|
913 |
| Current assets |
972
|
876
|
913 |
| Current liabilities |
339
|
272
|
376 |
| Equity capital |
614
|
577
|
499 |
| - share capital |
53
|
57
|
60 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
63.2%
|
65.9%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
14.6%
|
14.7%
|
13.6% |
| Return on assets (ROA) |
40.1%
|
45.2%
|
26.7% |
| Current ratio |
286.7%
|
322.1%
|
242.8% |
| Return on equity (ROE) |
52.4%
|
54.9%
|
46.9% |
| Change turnover |
189
|
525
|
372 |
| Change turnover % |
9%
|
32%
|
28% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.